Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Terence Cook

Showing results (181-190 of 210) with videos related to

Pageof 21
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2011
The inhibiting Fc receptor for IgG, FcγRIIB, is a modifier of autoimmune susceptibilityPeter Boross, Victoria L Arandhara, Javier Martin-Ramirez, et al.
Kidney International|February 21, 2018
Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indicesIngeborg M Bajema, Suzanne Wilhelmus, Charles E Alpers, et al.
American Journal of Nephrology|November 21, 2022
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor DanicopanSteven D Podos, Howard Trachtman, Gerald B Appel, et al.
Blood|July 3, 2004
Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapySimon N Waddington, Megha S Nivsarkar, Ajay R Mistry, et al.
Journal of the American Society of Nephrology : JASN|April 1, 2005
Membranoproliferative glomerulonephritis type II (dense deposit disease): an updateGerald B Appel, H Terence Cook, Gregory Hageman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 26, 2015
Selective Targeting of a Disease-Related Conformational Isoform of Macrophage Migration Inhibitory Factor Ameliorates Inflammatory ConditionsMichael Thiele, Randolf J Kerschbaumer, Frederick W K Tam, et al.
American Journal of Nephrology|November 24, 2022
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 StudiesCarla Nester, Gerald B Appel, Andrew S Bomback, et al.
Nature|February 17, 2006
Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humansTimothy J Aitman, Rong Dong, Timothy J Vyse, et al.
Nature Genetics|May 29, 2007
FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunityManuela Fanciulli, Penny J Norsworthy, Enrico Petretto, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 23, 2021
C3 Glomerulopathy and Related Disorders in Children: Etiology-Phenotype Correlation and OutcomesEdwin K S Wong, Kevin J Marchbank, Hannah Lomax-Browne, et al.
Pageof 21

Showing results (181-190 of 210) with videos related to

Sort By:
Pageof 21
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2011
The inhibiting Fc receptor for IgG, FcγRIIB, is a modifier of autoimmune susceptibilityPeter Boross, Victoria L Arandhara, Javier Martin-Ramirez, et al.
Kidney International|February 21, 2018
Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indicesIngeborg M Bajema, Suzanne Wilhelmus, Charles E Alpers, et al.
American Journal of Nephrology|November 21, 2022
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor DanicopanSteven D Podos, Howard Trachtman, Gerald B Appel, et al.
Blood|July 3, 2004
Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapySimon N Waddington, Megha S Nivsarkar, Ajay R Mistry, et al.
Journal of the American Society of Nephrology : JASN|April 1, 2005
Membranoproliferative glomerulonephritis type II (dense deposit disease): an updateGerald B Appel, H Terence Cook, Gregory Hageman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 26, 2015
Selective Targeting of a Disease-Related Conformational Isoform of Macrophage Migration Inhibitory Factor Ameliorates Inflammatory ConditionsMichael Thiele, Randolf J Kerschbaumer, Frederick W K Tam, et al.
American Journal of Nephrology|November 24, 2022
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 StudiesCarla Nester, Gerald B Appel, Andrew S Bomback, et al.
Nature|February 17, 2006
Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humansTimothy J Aitman, Rong Dong, Timothy J Vyse, et al.
Nature Genetics|May 29, 2007
FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunityManuela Fanciulli, Penny J Norsworthy, Enrico Petretto, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 23, 2021
C3 Glomerulopathy and Related Disorders in Children: Etiology-Phenotype Correlation and OutcomesEdwin K S Wong, Kevin J Marchbank, Hannah Lomax-Browne, et al.
Pageof 21